{"id":54031,"date":"2012-10-11T14:29:13","date_gmt":"2012-10-11T14:29:13","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/molecular-imaging-agents-targets-technology-markets-and-commercial-opportunities.php"},"modified":"2012-10-11T14:29:13","modified_gmt":"2012-10-11T14:29:13","slug":"molecular-imaging-agents-targets-technology-markets-and-commercial-opportunities","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/molecular-imaging-agents-targets-technology-markets-and-commercial-opportunities.php","title":{"rendered":"Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities"},"content":{"rendered":"<p><p>    NEW YORK, Oct. 11, 2012 \/PRNewswire\/ -- Reportlinker.com    announces that a new market research report is available in its    catalogue:  <\/p>\n<p>    Molecular Imaging Agents: Targets, Technology,    Markets, and Commercial Opportunities  <\/p>\n<p>    <a href=\"http:\/\/www.reportlinker.com\/p01009930\/Molecular-Imaging-Agents-Targets-Technology-Markets-and-Commercial-Opportunities.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=Medical_Imaging\" rel=\"nofollow\">http:\/\/www.reportlinker.com\/p01009930\/Molecular-Imaging-Agents-Targets-Technology-Markets-and-Commercial-Opportunities.html#utm_source=prnewswire&#038;utm_medium=pr&#038;utm_campaign=Medical_Imaging<\/a>  <\/p>\n<p>    Driven by advances in molecular probe design and biomarker    detection methodologies, new imaging agents that can improve    visualization of pathologies and cellular processes are    changing the practice of diagnostic medicine. The ability of    this new generation of contrast agents to detect metabolic    changes at the molecular level has significant potential for    improving visualization and quality of care. Targetable and    activatable imaging agents are gaining interest for a wide    range of diagnostic applications that include cardiology,    neurology and soft tissue tumor detection. The number of    healthcare conditions that can be effectively imaged    noninvasively is expanding as a result of these innovative    detection technologies. Targeted and activatable imaging agents    offer a unique capability to generate unambiguous images by    exploiting specific molecular targets, pathways or cellular    processes. This new wave of imaging agents signals a paradigm    shift in which the reagents take on new importance.  <\/p>\n<\/p>\n<p>    Highlights  <\/p>\n<p>     Analyzes and assesses emerging imaging diagnostic candidates,    their capabilities, benefits, limitations and potential  <\/p>\n<p>     Profiles development-stage imaging agents and examines their    clinical status and commercial prospects  <\/p>\n<p>     Analyzes key industry alliances and partnerships by imaging    modality, and examines the impact of next-generation imaging    candidates on future imaging markets  <\/p>\n<p>     Profiles market participants, their development activity and    business strategies  <\/p>\n<\/p>\n<p>Read more here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/ca.finance.yahoo.com\/news\/molecular-imaging-agents-targets-technology-114200945.html\" title=\"Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities\">Molecular Imaging Agents: Targets, Technology, Markets, and Commercial Opportunities<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEW YORK, Oct.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/molecular-imaging-agents-targets-technology-markets-and-commercial-opportunities.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-54031","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54031"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=54031"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/54031\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=54031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=54031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=54031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}